Suhua H. Chen
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Accelerated brain age in Moyamoya disease patients: a deep learning approach and correlation with disease severity.
Journal: Frontiers in neuroscience
Published: July 18, 2025
Significance of precise classification of sacral meningeal cysts by multiple dimensions radiographic reconstruction MRI in guiding operative strategy and rehabilitation
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: April 12, 2025
Discovery of GJC1 as a prognostic biomarker in glioma cells: insights into its cell-cycle relationship and differential expression in non-neuronal cells.
Journal: Frontiers in cellular neuroscience
Published: May 29, 2024
Reinforced radiculoplasty for the treatment of symptomatic sacral Tarlov cysts: A clinical analysis of 71 cases
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: January 31, 2023
Surgical treatment of large and giant recurrent meningiomas near the middle and posterior third part of the superior sagittal sinus with extracranial invading
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: October 14, 2022
Effect of glioma-derived immunoglobulin on biological function of glioma cells.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 06, 2022
CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.
Journal: Journal of molecular neuroscience : MN
Published: April 16, 2022
PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis.
Journal: Heliyon
Published: April 10, 2022
S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
Journal: World neurosurgery
Published: February 15, 2022
CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.
Journal: Scientific reports
Published: October 26, 2021
ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression.
Journal: Scientific reports
Published: August 18, 2021
Last Updated: 09/26/2026